Pre-hospital notification reduced the door-to-needle time for iv t-PA in acute ischaemic stroke

European Journal of Neurology

Volumn 16, Issue 12, 2009, Pages 1331-1335

  Kim, S K ^a   Lee, S Y ^a   Bae, H J ^a   Lee, Y S ^a   Kim, S Y ^a   Kang, M J ^a   Cha, J K ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

Door to needle time; Pre hospital notification; Stroke; T PA

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; ARTICLE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EMERGENCY CARE; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT TRANSPORT; PRIORITY JOURNAL; SCORING SYSTEM; STROKE; TELEPHONE; TIME; TREATMENT OUTCOME;

DELIVERY OF HEALTH CARE; EMERGENCY MEDICINE; EMERGENCY SERVICE, HOSPITAL; FEMALE; FIBRINOLYTIC AGENTS; HOTLINES; HUMANS; MALE; MIDDLE AGED; STROKE; TIME; TISSUE PLASMINOGEN ACTIVATOR;

EID: 70450173152     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02762.x     Document Type: Article

References (20)

1. The National Institute of Neurologic Disorder and Stroke rt-PA Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995 333 : 1581 1587.
2. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995 274 : 1017 1025.
3. Chiu D, Krieger D, Villar-Cordova C, et al. Intravenous tissue plasminogen activator for acute ischemic stroke. Feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998 29 : 18 22.
4. Smith MA, Doliszni KM, Shahar E, McGovern PG, Arnett DK, Luepker RV. Delayed hospital arrival for acute ischemic stroke: the Minnesota Stroke survey. Arch Intern Med 1998 129 : 190 196.
5. Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke. The Cleveland area experience. JAMA 2000 283 : 1151 1158.
6. Kyung-Ho Yu, Hee-Jun Bae, Sun Uck Kwon, et al. Analysis of 10,811 Cases with acute ischemic stroke from Korean Stroke Registry: Hospital-Based Multicenter Prospective Registration Study. J Korean Neurol Assoc 2006 24 : 535 543.
7. Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S. Pre-hospital and emergency department delays for acute stroke. Stroke 2000 31 : 2585 2590.
8. Castillo J, Davalos A, Martinez-Vila E. Latent period in attending patients with acute cerebrovascular disease: a multicenter study. Rev Neurol 1996 24 : 427 430.
9. Wester P, Radberg J, Lundren B, Peltonen M, Seek-Medical-Attention-in- Time Study Group. Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA: a prospective and multicenter study. Stroke 1999 30 : 40 48.
10. Koenecke HC, Nohr R, Leistner S, Marx P. Intravenous t-PA for ischemic stroke team performance over time, safety, and efficacy in a single center, 2-year experience. Stroke 2001 32 : 1074 1078.
11. Zweifler RM, Dinkard R, Cunningham S, Brody ML, Rothrock JF. Implementation of a stroke code system in Mobile, Alabama. Diagnostic and therapeutic yield. Stroke 1997 28 : 981 983.
12. Lyden PD, Rapp K, Babcock T, Rothrock J. Ultra-rapid identification, triage, and enrollment of stroke patients into clinical trials. J Stroke Cerebrovasc Dis 1994 4 : 106 113.
13. Nam HS, Han SW, Ahan SH, et al. Improved time intervals by implementation of computerized physician order entry-based stroke team approach. Cerebrovasc Dis 2007 23 : 289 293.
14. Adams HP Jr., del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007 38 : 1655 1711.
15. Brevis R, Cocho D, Marti-Fabreagas J, et al. Benefits of a prehospital stroke code system: feasibility and efficacy in the first year of clinical practice in Barocelona, Spain. Cerebrovasc Dis 2005 19 : 96 101.
16. Hacke W, Kaste M, Fieschi C, et al. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Second European - Australian Acute Stroke Study investigators. Lancet 1998 352 : 1245 1251.
17. Davalos A, Castillo J, Matinez-Vial E, for the Cerebrovascular Diseases Study group of the Spanish Society of Neurology. Delay in neurological attention and stroke outcome. Stroke 1995 26 : 2233 2237.
18. Barsan WG, Brott TG, Brosderick JP, Haley EC, Levy DE, Marler JR. Time of hospital presentation in patients with acute ischemic stroke. Arch Intern Med 1993 153 : 2558 2561.
19. Marler J, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke trial. Stroke 2000 31 : 2335 2341.
20. Tomsick TA. Intravenous thrombolysis for acute ischemic stroke. J Vasc Interv Radiol 2004 15 : S67 S76.